Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system

Transplantation

Volumn 61, Issue 3, 1996, Pages 448-457

  Wang, Min ^a   Stepkowski, Stanislaw M ^a   Wang, Mou Er ^a   Tian, Ling ^a   Qu, Xiumei ^a   Tu, Yizheng ^a   He, Gang ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ARTICLE; BACULOVIRUS; CELL CULTURE; CELL LYSATE; GRAFT SURVIVAL; IMMUNITY; IMMUNIZATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; BACULOVIRIDAE; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; LIVER TRANSPLANTATION; MALE; MELITTEN; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED LEW; RATS, INBRED WF; SOLUBILITY; SPODOPTERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030050467     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00024     Document Type: Article

References (61)

1. Amos DB, Gorer PA, Mikulska ZB. An analysis of an antigenic system in the mouse (the H-2 system). Proc R Soc Lond 1955; 144: 369.
2. Ascher NL, Hoffman RA, Hanto DW, Simmons RL. Cellular basis of allograft rejection. Immunol Rev 1984; 77: 217.
3. Jooste SV, Winn HJ. Acute destruction of rat skin grafts by alloantisera. J Immunol 1975; 11: 385.
4. Sherman LA, Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 1993; 11: 403.
5. Germain RN. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993; 11: 403.
6. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990; 59: 253.
7. b [see comments]. Science 1992; 257: 919.
8. Rammenesee HG, Folk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11: 213.
9. 2m MHC class I proteins, and CD8+ T cells. Science 1990; 148: 1227.
10. Williams DB, Barber BH, Flavell RA, Allen H. Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J Immunol 1989; 142: 2796.
11. Doxiadis I, Westhoff U, Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme immunoadsorbent assay. Blut 1989; 59: 449.
12. Zavazava N, Bottcher H, Muller-Ruchholtz W. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42: 20.
13. Tsuji K, Kusama M, Nakatsuji T, Kato S. Biological significance of Ss (serum soluble) HLA class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 1985; 10: 169.
14. De Vito-Haynes L, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994; 40: 191.
15. Stepkowski SM, Ito T. Frequency of alloantigen-specific T cytotoxic cells in high- and low-responder recipients of class I MHC disparate heart allografts. Transplantation 1990; 50: 112.
16. Gracie JA, Bolton EM, Poteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
17. + T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts. Transplant Proc 1993; 25: 885.
18. Spencer SC, Fabre JW. Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation 1987; 44: 141.
19. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
20. Fangmann J, Dalchau R, Sawyer GJ, Priestley CA, Fabre JW. T cell recognition of donor major histocompatibility complex class I peptide during allograft rejection. Eur J Immunol 1992; 22: 1525.
21. Nisco S, Vriens P, Hoyt G, et al. Induction of allograft tolerance in rats by an HLA class I -derived peptide and cyclosporine A. J Immunol 1994; 152: 3786.
22. Seyegh MH, Perico N, Gallon L, et al. Mechanism of acquired thymic unresponsiveness to renal allografts. Transplantation 1994; 58: 125.
23. Rada C, Lorenzi R, Powis SJ, van den Bogaerde J, Parham P, Howard JC. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
24. Sambrook J, Fritsch EF, Maniatis T. Essential features of plasmids. In: Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning, 2nd ed. Cold Harbor Spring, NY: Cold Spring Harbor Laboratory Press, 1989: 1.
25. Luckow VA, Summers MD. Trends in the development of baculovirus expression vectors. Bio/Technology 1988; 6: 47.
26. Luckow VA, MD. Summers. High level expression of nonfused foreign genes with sutographa californica nuclear polyhedrosis virus expression vectors. Virology 1989; 170: 31.
27. Tessier DC, Thomas DY, Khouri HE, Laliberte F, Vernet T. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene 1991; 98: 177.
28. Frohman MA, Dush MK, Martin GR. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene specific oligonucleotide primer. Proc Natl Acad Sci USA 1988; 85: 8998.
29. Sambrook J, Fritsch EF, Maniatis T. Immunological screening of expression libraries: essential features of plasmids. In: Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning, 2nd ed. Cold Harbor Spring, NY: Cold Spring Harbor Laboratory Press, 1989: 2.
30. Spencer SC, Fabre JW. Water soluble form of RT-1A class I MHC molecules in the kidney and liver of the rat. Immunogenetics 1987; 25: 91.
31. Dreyfuss G, Adam SA, Choi YD. Physical change in cytoplasmic nucleoproteins in cells treated with inhibitors of mRNA transcription. Mol Cell Biol 1984; 4: 415.
32. Ono K, Lindsey E. Improved technique for heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
33. Lee S, Charter AC, Chandler JG, Orloff MJ. A technique for orthotopic liver transplantation in the rat. Transplantation 1965; 16: 664.
34. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells. J Cell Biol 1969; 45: 506.
35. Alfrey EJ, Wang X, Lee L, et al. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents. Transplantation 1995; 59: 1171.
36. Shirwan H, Learner M, Wang HK, Makowka L, Cramer DV. Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
37. Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells [see comments]. Nature 1990; 348: 252.
38. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506.
39. b molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci USA 1992; 89: 8403.
40. Perloff LJ, Baker CF. Variable response to donor-specific blood transfusion in the rat. Transplantation 1994; 38: 178.
41. Wasowska B, Baldwin WM, Howell DN, Sanfilippo F. The effects of donor-specific blood transfusion enhancement of rat renal allograft on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells. Transplantation 1991; 51: 451.
42. Oluwole SF, Ng AK, Reemtsra K, Hardy M. The mechanism of the induction of immunologic unresponsiveness to rat cardiac allograft by recipient pretreatment with donor lymphocyte subsets. Transplantation 1991; 48: 281.
43. Wood ML, Monaco AP, Gottschalk R. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice. Transplantation 1991; 51: 208.
44. Medawar PB. The use of antigenic tissue to weaken the immunological reaction against skin homografting mice. Transplantation 1963; 1: 21.
45. Myburgh JA, Smit JA. Prolongation of liver allograft survival by donor-specific soluble transplantation antigens and antigen-antibody complexes. Transplantation 1975; 19: 64.
46. Yasumura T, Kahan BD. Prolongation of rat kidney allograft by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. Transplantation 1983; 36: 603.
47. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation 1985; 39: 56.
48. Qian JH, Hashimoto T, Fujiwara H, Hamaoka T. Studies on induction of tolerance to alloantigens. I. The abrogation of potential for delayed type hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1985; 34: 3656.
49. Rao VK, Burns DE, Gruel SM, Sollinger HW, Burlingham WJ. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allograft in rats. Transplantation 1988; 45: 1145.
50. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990; 249: 1293.
51. Markmann JF, Odorico JS, Bassiri H, Desai N, Kim JI, Barker CF. Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 1993; 55: 871.
52. Kenick S, Lisbona R, Marghesco D, Lowry RP. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: immunologically specific entrapment of allogeneic cells within the liver. Transplant Proc 1987; 19: 3057.
53. Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mori T. Permanent acceptance of liver allograft by intraportal injection of donor spleen cells in rats. Surgery 1992; 111: 668.
54. Odorico JS, Barker CF, Posselt AM, Naji A. Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery 1992; 112: 370.
55. Remuzzi G, Rossini M, Imberti O, Perico N. Kidney graft survival in rats without immunosuppressants after intrathymic glomeruli transplantation. Lancet 1991; 337: 750.
56. Oluwole SF, Chowdhury NC, Fawwaz RA. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic of UV-B irradiate donor spleen cells. Transplantation 1993; 55: 1389.
57. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57: 990.
58. 2-microglobulin type A in insect cells infected with recombinant baculovirus. Res Immunol 1992; 142: 409.
59. 2-microglobulin co-expression. Int Immunol 1992; 4: 265.
60. 2-microglobulin expressed in the baculovirus-insect cell system. J Biol Chem 1992; 34: 24223.
61. Stern LJ, Wiley DC. The human class II MHC protein HLA-DR1 assembles as empty α/β heterodimers in the absence of antigenic peptide. Cell 1992; 68: 465.